ea0049ep889 | Neuroendocrinology | ECE2017
Refardt Julie
, Winzeler Bettina
, Meienberg Fabian
, Vogt Deborah
, Christ-Crain Mirjam
Introduction: The Syndrome of inappropriate antidiuresis (SIADH) is the predominant cause of hyponatremia and its therapy options are unsatisfying. SGLT2-inhibitors have become a valuable treatment option for type 2 diabetes by increasing glucose excretion in the urine with concomitant osmotic diuresis. We therefore hypothesized that SGLT2-inhibitors could be a novel treatment option for SIADH.Material and methods: We included 14 healthy volunteers in th...